CS binding inhibits TCR dimerization and thereby prevents the formation of the MHC: TCR complex, impairing the infiltration of effector T cells into tumor tissues and thereby leading to tumor immune evasion [117]. The gene discussed is HLA-C; the disease is neoplasm.